|
⚲
|
| Keyboard |
| Paul Andrea
✚
|
|
|---|---|
| CIK # | 0001863130 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001863130] | |
| 4 | [0001863130] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Zentalis Pharmaceuticals Inc | |
| Paul Andrea | |
| LogicBio Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2025-02-03 | Grant | 934,041 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
|
2025-02-03 | Grant | 124,714 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2025-02-03 | Sell | 13,230 | $1.71 | 22,623 |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2024-02-02 | Sell | 3,310 | $11.54 | 38,197 |
|
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
|
2024-02-01 | Grant | 90,000 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2024-02-01 | Grant | 112,500 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
|
2024-02-01 | Grant | 112,500 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
|
2023-02-01 | Grant | 59,217 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2023-02-01 | Grant | 40,783 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
|
2022-08-01 | Grant | 290,500 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2022-03-01 | Grant | 80,000 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Employee Stock Option (Right to buy) · derivative
|
2021-05-17 | Grant | 165,000 | $0.00 |